In a game-changing development that promises to redefine the contours of life science research, Novogene, the global titan in molecular biology technologies, has earned the prestigious Olink® Certified Service Provider (CSP) designation across multiple laboratories worldwide. This recognition underscores its unwavering commitment to scientific brilliance, data accuracy, and the relentless pursuit of illuminating the enigmatic universe of proteomics.
This significant certification heralds a new era for Novogene, allowing the firm to bolster its proteomics portfolio and provide high-throughput, high-quality protein biomarker discovery services. This development enables Novogene to deepen its investment in life science innovation, propelling the company to the forefront of molecular biology.
In the complex and rapidly evolving realm of life sciences, Novogene’s certification is more than just a seal of approval. It’s a testament to the company’s capacity to execute Olink® workflows with unparalleled precision, consistency, and scalability. This capacity is pivotal in fostering advanced translational research and precision medicine for a vast network of partners across pharmaceutical, biotech, and academic fields.
The expansion of Novogene’s proteomics suite with the addition of Olink® Reveal is particularly noteworthy. This platform enables the quantification of approximately 1,000 curated human proteins, including 537 inflammation markers, covering an astounding 96% of immune response pathways and 64% of all Reactome pathways. This vast array of quantifiable proteins presents researchers with a powerful tool to delve into the intricacies of inflammatory biology and boost biomarker discovery, translational research, and precision medicine.
Novogene’s VP of Global Marketing, Justin Lee, expressed his delight at this recognition, stating that the certification underlines their commitment to delivering high-quality, globally harmonized data. With Olink® Reveal offering invaluable insights into inflammatory biology, researchers are now empowered to accelerate their efforts in critical areas of life science research.
Equally ecstatic about this partnership is Andrea Ballagi, Olink VP of Sales and Marketing, who lauded Novogene’s instrumental role in the global network of Olink® Certified Service Providers. This collaboration not only amplifies Novogene’s leadership in comprehensive multi-omics solutions but also promises to push the boundaries of proteogenomic applications.
As we stand on the precipice of a new era in life sciences, partnerships such as this between Novogene and Olink® are more crucial than ever. By delivering reproducible, high-quality data, they are empowering scientists around the world to make groundbreaking discoveries, unravel disease mechanisms, identify therapeutic targets, and advance biomarker research. In doing so, they are catalyzing a healthier, cleaner, and safer world for us all.
Read more from finance.yahoo.com
